Trial
NCT01393119
Phase II, Dose Finding Study of GTx-758
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
GTx
Collaborators
—
Condition
Prostate Cancer
Intervention
GTx-758
Why stopped
FDA Clinical Hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-22